adalimumab (preferred products) — Highmark
Psoriatic Arthritis (PsA) without spinal or axial disease
Initial criteria
- age ≥ 18 years
- diagnosis of PsA without spinal disease
- prescribed by or in consultation with a rheumatologist or dermatologist
- experienced therapeutic failure or intolerance to at least one non-biologic DMARD (for example, methotrexate, leflunomide, sulfasalazine, cyclosporine) OR all non-biologic DMARDs are contraindicated
Reauthorization criteria
- member has demonstrated disease stability or a beneficial response to therapy